C Stumptner

Author PubWeight™ 14.82^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Atypical ductular proliferation and its inhibition by transforming growth factor beta1 in the 3,5-diethoxycarbonyl-1,4-dihydrocollidine mouse model for chronic alcoholic liver disease.	Lab Invest	1999	2.16
2	Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.	Hepatology	2001	1.92
3	Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver.	Gastroenterology	2001	1.32
4	Mallory bodies revisited.	J Hepatol	2000	1.24
5	Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies.	Am J Pathol	2000	1.21
6	Mallory-Denk-bodies: lessons from keratin-containing hepatic inclusion bodies.	Biochim Biophys Acta	2008	1.17
7	Are the Mallory bodies and intracellular hyaline bodies in neoplastic and non-neoplastic hepatocytes related?	J Pathol	2006	1.12
8	Intermediate filament cytoskeleton of the liver in health and disease.	Histochem Cell Biol	2008	0.99
9	Disturbance of keratin homeostasis in griseofulvin-intoxicated mouse liver.	Lab Invest	1993	0.90
10	[Alcoholic and nonalcoholic steatohepatitis. Histopathologic and pathogenetic considerations].	Pathologe	2001	0.81
11	Experimental Mallory body formation is accompanied by modulation of the expression of multidrug-resistance genes and their products.	Hepatology	1996	0.78
12	How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.	Pathobiology	2007	0.77
13	Altered microtubule-associated tau messenger RNA isoform expression in livers of griseofulvin- and 3,5-diethoxycarbonyl-1, 4-dihydrocollidine-treated mice.	Hepatology	1999	0.76
14	[Alcoholic and non-alcoholic steatohepatitis].	Verh Dtsch Ges Pathol	2005	0.75